Researchers have designed a machine learning algorithm that predicts the outcome of chemical reactions with much higher accuracy than trained chemists and suggests ways to make complex molecules, removing a significant hurdle in drug discovery.
Our platform is like a GPS for chemistry
University of Cambridge researchers have shown that an algorithm can predict the outcomes of complex chemical reactions with over 90% accuracy, outperforming trained chemists. The algorithm also shows chemists how to make target compounds, providing the chemical ‘map’ to the desired destination. The results are reported in two studies in the journals ACS Central Science and Chemical Communications.
A central challenge in drug discovery and materials science is finding ways to make complicated organic molecules by chemically joining together simpler building blocks. The problem is that those building blocks often react in unexpected ways.
“Making molecules is often described as an art realised with trial-and-error experimentation because our understanding of chemical reactivity is far from complete,” said Dr Alpha Lee from Cambridge’s Cavendish Laboratory, who led the studies. “Machine learning algorithms can have a better understanding of chemistry because they distil patterns of reactivity from millions of published chemical reactions, something that a chemist cannot do.”
The algorithm developed by Lee and his group uses tools in pattern recognition to recognise how chemical groups in molecules react, by training the model on millions of reactions published in patents.
The researchers looked at chemical reaction prediction as a machine translation problem. The reacting molecules are considered as one ‘language,’ while the product is considered as a different language. The model then uses the patterns in the text to learn how to ‘translate’ between the two languages.
Using this approach, the model achieves 90% accuracy in predicting the correct product of unseen chemical reactions, whereas the accuracy of trained human chemists is around 80%. The researchers say that the model is accurate enough to detect errors in the data and correctly predict a plethora of difficult reactions.
The model also knows what it doesn’t know. It produces an uncertainty score, which eliminates incorrect predictions with 89% accuracy. As experiments are time-consuming, accurate prediction is crucial to avoid pursuing expensive experimental pathways that eventually end in failure.
In the second study, Lee and his group, collaborating with the biopharmaceutical company Pfizer, demonstrated the practical potential of the method in drug discovery.
The researchers showed that when trained on published chemistry research, the model can make accurate predictions of reactions based on lab notebooks, showing that the model has learned the rules of chemistry and can apply it to drug discovery settings.
The team also showed that the model can predict sequences of reactions that would lead to a desired product. They applied this methodology to diverse drug-like molecules, showing that the steps that it predicts are chemically reasonable. This technology can significantly reduce the time of preclinical drug discovery because it provides medicinal chemists with a blueprint of where to begin.
“Our platform is like a GPS for chemistry,” said Lee, who is also a Research Fellow at St Catharine’s College. “It informs chemists whether a reaction is a go or a no-go, and how to navigate reaction routes to make a new molecule.”
The Cambridge researchers are currently using this reaction prediction technology to develop a complete platform that bridges the design-make-test cycle in drug discovery and materials discovery: predicting promising bioactive molecules, ways to make those complex organic molecules, and selecting the experiments that are the most informative. The researchers are now working on extracting chemical insights from the model, attempting to understand what it has learned that humans have not.
“We can potentially make a lot of progress in chemistry if we learn what kinds of patterns the model is looking at to make a prediction,” said Peter Bolgar, a PhD student in synthetic organic chemistry involved in both studies. “The model and human chemists together would become extremely powerful in designing experiments, more than each would be without the other.”
The Latest on: Drug discovery
via Google News
The Latest on: Drug discovery
- New drug combo may improve pancreatic cancer therapy on November 18, 2019 at 3:26 pm
A new study by scientists at Sanford Burnham Prebys Medical Discovery Institute have discovered a combination of two cancer-fighting ... The observed efficacy of this two-drug combo, using newer ...
- One-two punch drug combination offers hope for pancreatic cancer therapy on November 18, 2019 at 8:03 am
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a combination of two anti-cancer compounds that shrank pancreatic tumors in mice—supporting the immediate evaluation of ...
- Novartis switches gears in Shanghai from research to drug development on November 18, 2019 at 6:51 am
Novartis is exiting drug discovery at its Shanghai site and shifting its focus to drug development, saying accelerating approvals in China are pushing the Swiss company to dedicate the operation's ...
- Propanc Biopharma Advances POP1 Drug Discovery Program on November 18, 2019 at 4:30 am
Propanc Biopharma, Inc. (OTC: PPCB) ("Propanc” or the "Company”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced ...
- Drug-discovery firm nets $14.5M in Series A funding on November 17, 2019 at 7:06 am
“We think that this is an approach and a technology that is really going to transform drug discovery across the board,” said Dr. David Collier, CEO of X-37, which is partly owned by Atomwise ...
- Drug Discovery Market Size, Share, Industry Growth Analysis by Top 10 Players In The Globe Forecast 2026 on November 15, 2019 at 3:33 am
Real-time insights with the help of drug discovery is a key factor driving the global drug discovery market, says Fortune Business Insights in a report, titled “Drug Discovery Informatics Market Size, ...
- GlaxoSmith Kline (GSK): Seeking AI and ML experts for data-driven drug discovery and development on November 14, 2019 at 12:03 pm
GlaxoSmithKline (GSK) is creating a data-focused culture and a global machine-learning team. GlaxoSmithKline’s (GSK’s) data-first approach to drug discovery and development comes directly from chief ...
- Startup X-37 Raises $14.5M to Expand on AI-Powered Drug Discovery on November 14, 2019 at 8:49 am
Launched just last year, artificial intelligence-powered drug discovery company X-37 now has raised $14.5 million in Series A financing to expand its development programs. The startup was co ...
- Drug Discovery Informatics Market In-deep Analysis and Clinical Aspect Review 2019-2025 on November 13, 2019 at 1:16 am
Nov 13, 2019 (Market Insight Reports via COMTEX) -- The global Drug Discovery Informatics Market is carefully researched in the report while largely concentrating on top players and their business ...
- Drug Discovery Technologies Market 2019 by Excellent Revenue Growth by 2025 | MRE Research Report on November 12, 2019 at 10:08 am
Nov 12, 2019 (Heraldkeepers) -- New York, November 12, 2019: The global Drug Discovery Technologies market report provides geographic analysis covering regions, such as North America, Europe, ...
via Bing News